A Novel Point Mutation at Position 156 of Reverse Transcriptase from Feline Immunodeficiency Virus Confers Resistance to the Combination of (−)-β-2′,3′-Dideoxy-3′-Thiacytidine and 3′-Azido-3′-Deoxythymidine

Ítems similars

• Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine.
  per: Remington, K M, et al.
  Publicat: (1991)
• Multiple-drug-resistant mutants of feline immunodeficiency virus selected with 2',3'-dideoxyinosine alone and in combination with 3'-azido-3'-deoxythymidine.
  per: Gobert, J M, et al.
  Publicat: (1994)
• A New Point Mutation (P157S) in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Confers Low-Level Resistance to (−)-β-2′,3′-Dideoxy-3′-Thiacytidine
  per: Smith, Robert A., et al.
  Publicat: (1999)
• Mutants of feline immunodeficiency virus resistant to 2',3'-dideoxy-2',3'-didehydrothymidine.
  per: Zhu, Y Q, et al.
  Publicat: (1996)
• 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase.
  per: St Clair, M H, et al.
  Publicat: (1987)